Omeros Corporation Garners $20,000,000 New Round

  • Feed Type
  • Date
    9/24/2008
  • Company Name
    Omeros Corporation
  • Mailing Address
    1420 Fifth Avenue Seattle, WA 98101
  • Company Description
    Omeros recognized that a combination of agents acting on multiple molecular targets may be required for optimal therapeutic effect. Omeros’ product candidates are designed to modulate the molecular mechanisms of pathologic conditions rather than just treating their symptoms.
  • Website
    http://www.omeros.com
  • Transaction Type
    Debt
  • Transaction Amount
    $20,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    BlueCrest Capital Finance LP

By posting a comment, you agree to our terms and conditions.